In a controlled clinical trial Truelove (1960) showed that a daily dose of 1 mg. of stilboestrol given for six months had a beneficial effect on the course of duodenal ulcer in man. Further evidence that ovarian function may influence duodenal ulceration is provided by the fact that women are less liable to develop duodenal ulcer than men (White, 1951; Doll, 1952) , although after the menopause the incidence rises (Borri, 1904) ; that the incidence of complications of duodenal ulcer in women increases after the menopause (Clark, 1953) ; and that pregnancy has a beneficial effect on the symptoms of duodenal ulcer (Clark, 1953) .
To date, no clear evidence has emerged to account for these features. Animal experiments to assess the effect of oestrogens on gastric secretion have been contradictory and vitiated by species variations (Sandweiss, Saltzstein, and Farbman, 1938; Culmer, Atkinson, and Ivy, 1939; Ojha and Wood, 1950; Lozzio, Gagliardi, Biempica, and Royer, 1961; Antonsen, 1955; Singh and Shukla, 1959) . In man, Baron (1963) has shown that women secrete less acid than men, which substantiates an earlier report by Vanzant, Alvarez, Eusterman, Dunn, and Berkson (1932) . It has been claimed, however, that this difference is a function of lean body mass and not related to sex (Card, 1952) . Baron (1964) , however, was unable to demonstrate any correlation between body mass and gastric acid secretion.
Equally, studies of acid output by the stomach in pregnancy are inconclusive. Strauss and Castle (1932) reported reduced acid secretion in response to histamine and alcohol during pregnancy. Clark and Tankel (1954) , on the other hapd, were unable to ' This work was undertaken during the tenure of a British Council fellowship. "Present address: Department of Surgery, University of Newcastleupon-Tyne. detect any change in the basal and augmented histamine output of acid and pepsin in nine women studied monthly throughout pregnancy although others found a reduction in the histamine-stimulated secretion during the second trimester (Murray, Erskine, and Fielding, 1957; Hunt and Murray, 1958) .
This study therefore aims to determine in man with active duodenal ulceration the effect of oestrogens and progestogens on gastric acid and pepsin and mucus secretion.
PATIENTS AND METHODS
EFFECT OF ORAL OESTROGEN AND PROGESTOGEN Twentyfour patients with symptoms and radiological evidence of duodenal ulcer cooperated in this study. Patients were divided into three treatment groups, A, B, or C. Patients in group A were given stilboestrol 5 mg. twice a day, those in group B received norethisterone 5 mg. twice a day, and those in group C were given two placebo tablets per day. Of 15 patients started on stilboestrol, five were withdrawn from the trial because of nausea and vomiting. All 10 patients who were given progestogen and all 10 patients given placebo successfully completed the course. There were thus 30 successful treatment periods involving 19 patients available for analysis. Where the same subject had more than one treatment the order of administration was varied. Studies of gastric secretion were done under control conditions in all patients before the beginning of treatment and subsequently at the end of each treatment period. EFFECT Gastric secretory studies were carried out by the method of Kay (1953) clinically assessed before and after therapy by one of us (S.P.P.). The overall assessment is summarized in Table I . Of 10 patients completing oestrogen Figure 2 shows the increase of nitrogen in the basal secretion in eight out of the 10 patients studied. Increased nitrogen levels were also noted in the posthistamine secretion following oestrogen and progestogen. A summary of the data is presented in Table III .
Secretion of mucus An increase in visible mucus occurred after both stilboestrol and norethisterone in the basal and post-histamine juices (Table IV) .
Peptic activity The results are summarized in Table V The pH of acid did not alter significantly nor was 6 , 0-rthere any change in the basal output (Table VI) (Table VII) . (Table VII) . in gastric juice (basal secretion).
As shown in Table VII , there was no significant change in peptic activity. Figure 3 . No significant change in acid output was observed, although with very low dosages of histamine (mean 0-046 ug. per kilogram body weight per min.) inhibition of 52 % and 39 % occurred in two out of three cases where the mean basal secretion in one hour was 5-04 mEq., mean histamine-stimulated secretion 13-07 mEq. per hour, and the mean post-oestrogen secretion over one hour was 8-68 mEq. In all cases on the higher dosage of histamine previously mentioned there were rises in 
DISCUSSION
The results of our investigations indicate that an elevation of the blood level of oestrogens has no effect on the secretion of acid or pepsin by the stomach and are in agreement with previous clinical investigations (Albers, 1940; Kirsner, 1963) . These results are in conflict with those of Ojha and Venkatachalam (1951) who reported that daily doses of 10 mg. of stilboestrol reduced the 'free' acid output after 10 days using the fractional test meal. The replicability of this test is poor and interpretation of the results is difficult.
In contrast to these reports is the observation of Abrahamson, Church, and Hinton (1942) that the 'free' and 'total' output of acid rose in a group of men with chronic duodenal ulcer treated with oestrogens. It is of interest that all these patients showed The protection afforded by pregnancy against duodenal ulceration and its complications in the presence of high blood levels of both oestrogens and progestogens must be due to factors other than changes in acid output. Interestingly enough, Kahlson, Lilja, and Svensson (1964) have shown protection against gastric ulceration during pregnancy in rats in the presence of raised acid output.
The resistance against digestion is provided by many factors, most of which are still poorly understood, including mucus, rapid epithelial turnover and migration, secretion of proteolytic ferments in the inactive form in the basal part of the gastric glands, and gastric urease, and it may be that oestrogens exert a beneficial influence on duodenal ulceration by altering the secretion of mucus. Oestrogens and progestogens are known to increase secretion of mucus in other parts of the body, such as the cervical canal, and further detailed studies of oestrogenic action on the components of gastric mucus are required. In this study the visible mucus was noted to increase after oestrogen treatment but its accurate measurement proved difficult. The total nitrogen content of the samples of gastric juice was used as a rough index of mucus content and a significant increase was observed after treatment. Since measurements were of total nitrogen, changes in gastric urease activity should not alter these results. No estimations of gastric juice or mucosal urease were made in this study.
The clinical benefit of oestrogens in the treatment of duodenal ulcer has been demonstrated once more but whether this is a practical method of treatment is doubtful. The side effects in men of prolonged high doses of oestrogens are undesirable and the endocrine changes produced by these doses in women preclude their routine clinical use.
SUMMARY
A blind trial of treatment showed that oral doses of stilboestrol were effective in controlling the symptoms of duodenal ulcer but had no effect on the basal or augmented histamine secretion of acid or pepsin. Intramuscular injections of the progestogen, 17ahydroxyprogesterone caproate, lowered the gastric acid output.
Intravenous infusions of oestrogens did not alter the rate of histamine-stimulated secretion of acid.
Total gastric nitrogen was increased after oestrogen treatment. It is suggested that this reflects an increased production of mucus following oestrogen therapy.
